Tekla Life Sciences Inves...

NYSE: HQL · Real-Time Price · USD
13.82
0.17 (1.25%)
At close: Aug 15, 2025, 3:59 PM
13.86
0.29%
After-hours: Aug 15, 2025, 05:16 PM EDT

Tekla Life Sciences Investors Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Sep 30, 2024 Mar 31, 2024 Sep 30, 2023 Mar 31, 2023 Sep 30, 2022 Mar 31, 2022 Sep 30, 2021 Mar 31, 2021
Revenue
1.91M 2.07M 29.56M 1.93M 21.69M 10.17M 15.98M 29.03M
Cost of Revenue
n/a n/a 2.59M n/a 2.64M 2.91M 3.1M 2.97M
Gross Profit
1.91M 2.07M 26.97M 1.93M 19.05M 7.27M 12.87M 26.06M
Operating Income
-1.27M -653.34K -11.45M -940.75K -28.31M -76.3M 32.97M 31.56M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
35.04M 50.26M -11.45M 33.8M -28.31M -76.3M 32.98M 31.55M
Net Income
35.04M 50.26M -11.45M 33.8M -28.31M -76.3M 32.98M 31.55M
Selling & General & Admin
3.18M 2.72M n/a 2.87M 1.44M 1.56K 1.65K 1.56K
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a -38.42M n/a -47.35M n/a n/a n/a
Operating Expenses
3.18M 2.72M 38.42M 2.87M 14.95M 38.87K 15.9K 15.22K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
16.49K 8.11K n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.18M 2.72M 41.01M 2.87M 50M 86.47M -16.99M -2.52M
Income Tax Expense
n/a n/a -43.81K n/a n/a -843.92 -1.06K -1.01K
Shares Outstanding (Basic)
28.77M 27.35M 26.79M 26.21M 25.68M 25.14M 24.67M 24.28M
Shares Outstanding (Diluted)
28.77M 27.35M 26.79M 26.21M 25.68M 25.14M 24.67M 24.28M
EPS (Basic)
1.22 1.84 -0.43 1.29 -1.1 -3.03 1.34 1.30
EPS (Diluted)
1.22 1.84 -0.43 1.29 -1.1 -3.03 1.34 1.30
EBITDA
n/a 100.51M -11.45M n/a -28.31M -76.3M 32.97M 31.56M
EBIT
-1.27M 100.51M -11.45M -940.75K -28.31M -76.3M 32.97M 31.56M
Depreciation & Amortization
1.27M 653.33K 43.81K 940.75K 651.14K 843.92 1.06K 1.01K